MADISON BOLES: Open Payments
NPI 1225501927 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 97 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $1,107 · 2025 $2,215
Food & beverage: $2,115Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $340 |
| Janssen Biotech, Inc. | 9 | $278 |
| Merck Sharp & Dohme LLC | 11 | $257 |
| Novartis Pharmaceuticals Corporation | 6 | $120 |
| PFIZER INC. | 6 | $106 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Gilead Sciences, Inc. | 3 | $74 |
| Coherus Oncology, Inc. | 3 | $67 |
| Exelixis Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
Products named: KEYTRUDA, CALQUENCE, DARZALEX, ENHERTU, ERLEADA, Trodelvy, ELREXFIO, CABOMETYX.
Industry payments across GA — which companies pay providers there.
